These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Chemokines and Chemokine Receptors in the Development of NAFLD. Roh YS; Seki E Adv Exp Med Biol; 2018; 1061():45-53. PubMed ID: 29956205 [TBL] [Abstract][Full Text] [Related]
26. Expression of chemokines and chemokine receptors during human renal transplant rejection. Segerer S; Cui Y; Eitner F; Goodpaster T; Hudkins KL; Mack M; Cartron JP; Colin Y; Schlondorff D; Alpers CE Am J Kidney Dis; 2001 Mar; 37(3):518-31. PubMed ID: 11228176 [TBL] [Abstract][Full Text] [Related]
27. Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines. Cockwell P; Calderwood JW; Brooks CJ; Chakravorty SJ; Savage CO Nephrol Dial Transplant; 2002 May; 17(5):734-44. PubMed ID: 11981057 [TBL] [Abstract][Full Text] [Related]
29. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757 [TBL] [Abstract][Full Text] [Related]
30. Atypical chemokine receptors-"chemokine PACMANs" as new therapeutic targets in glomerulonephritis. Eller K; Rosenkranz AR Kidney Int; 2018 Apr; 93(4):774-775. PubMed ID: 29571448 [TBL] [Abstract][Full Text] [Related]
31. Complement C5a receptors C5L2 and C5aR in renal fibrosis. Martin IV; Bohner A; Boor P; Shagdarsuren E; Raffetseder U; Lammert F; Floege J; Ostendorf T; Weber SN Am J Physiol Renal Physiol; 2018 Jan; 314(1):F35-F46. PubMed ID: 28903945 [TBL] [Abstract][Full Text] [Related]
32. Serum concentrations of chemokines (CCL-5 and CXCL-12), chemokine receptors (CCR-5 and CXCR-4), and IL-6 in patients with posttraumatic stress disorder and avoidant personality disorder. Ogłodek EA; Szota AM; Moś DM; Araszkiewicz A; Szromek AR Pharmacol Rep; 2015 Dec; 67(6):1251-8. PubMed ID: 26481549 [TBL] [Abstract][Full Text] [Related]
33. Chemokines and chemokine receptors in rheumatoid arthritis. Szekanecz Z; Kim J; Koch AE Semin Immunol; 2003 Feb; 15(1):15-21. PubMed ID: 12495637 [TBL] [Abstract][Full Text] [Related]
35. A burgeoning family of biological mediators: chemokines and chemokine receptors. Le Y; Gong W; Shen W; Li B; Dunlop NM; Wang JM Arch Immunol Ther Exp (Warsz); 2000; 48(3):143-50. PubMed ID: 10912618 [TBL] [Abstract][Full Text] [Related]
37. Targeting Bone Marrow-Derived Fibroblasts for Renal Fibrosis. An C; Jia L; Wen J; Wang Y Adv Exp Med Biol; 2019; 1165():305-322. PubMed ID: 31399971 [TBL] [Abstract][Full Text] [Related]
38. Letter to Editor: Chemokine Network Involved in Inflammatory Skin Diseases. Shaik-Dasthagirisaheb YB; Conti P Ann Clin Lab Sci; 2015; 45(4):452-7. PubMed ID: 26275700 [TBL] [Abstract][Full Text] [Related]
39. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells. Gouwy M; Struyf S; Leutenez L; Pörtner N; Sozzani S; Van Damme J Immunobiology; 2014 Mar; 219(3):218-29. PubMed ID: 24268109 [TBL] [Abstract][Full Text] [Related]
40. The chemokine system and its contribution to leukemogenesis and treatment responsiveness in patients with acute myeloid leukemia. Olsnes AM; Hatfield KJ; Bruserud Ø J BUON; 2009 Sep; 14 Suppl 1():S131-40. PubMed ID: 19785055 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]